ERYtech Pharma (Lyon, Philadelphia) is a specialty pharma developing new high value medicinal products for unmet clinical needs in the fields of oncology, hematology and immunology.

Its business model consists both of developing and selling new innovative medicinal products and of partnering its R&D platform with pharma/biotech companies.

ERYtech Pharma’s patented technology and R&D platform offer large possibilities to create new products and IP on an industrial scale.

ERYtech Pharma has built in less than six years a strong pipeline with very ambitious programs.

The ambition of the company is to become a world leader in the pharmaceutical industry using red blood cells.